Roundtable Discussion; The Future of Mineral Sands. Watch the video here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksAstrazeneca Share News (AZN)

Share Price Information for Astrazeneca (AZN)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 12,050.00
Bid: 12,038.00
Ask: 12,040.00
Change: -106.00 (-0.87%)
Spread: 2.00 (0.017%)
Open: 12,092.00
High: 12,178.00
Low: 12,010.00
Prev. Close: 12,156.00
AZN Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Sunday newspaper round-up: Brexit, Coronavirus, AstraZeneca

Sun, 13th Dec 2020 18:57

(Sharecast News) - Britain and the EU have taken a step forward towards striking a post-Brexit trade and security deal after Boris Johnson and Ursula von der Leyen agreed to "go the extra mile" and ordered the resumption of talks in Brussels. The prime minister played down expectations following the telephone conversation with the European commission president, telling the cabinet to prepare for a no-deal exit when the transition period ends in three weeks' time. But in Brussels, EU embassies were briefed by the commission that "progress has been made" and that "the next days will be important". - Guardian

Britain could be "back to normal" by summer as long as it avoids a third wave after Christmas, the British scientist behind a Covid vaccine has said. Professor Sarah Gilbert, the lead researcher on the Oxford vaccine, said "people's behaviour in the coming weeks is going to have a big impact" on when facemasks and social distancing requirements can be dropped. She said that a spike in coronavirus cases in January would disrupt vaccination programmes. - Sunday Times

Britain's biggest maker of pharmaceuticals has swooped on an American rival in a daring move on the eve of Brexit. Astra Zeneca, the FTSE 100 drug-maker playing a central role in the fight against Covid-19, has agreed to buy Alexion Pharmaceuticals for $39bn (£28.9bn). The cash-and-shares deal will cement the Anglo-Swedish giant's position in immunology and give it a dedicated rare disease business based in Boston, Massachusetts. - Sunday Times

Keith Williams is a man of many modes of transport. The corporate veteran spent 18 years at airline British Airways - the final five as chief executive and chairman - and will in the New Year publish his long-awaited review into the rail industry. Now he is the boss of Royal Mail - and drones are firmly on his radar. Williams wants to use the unmanned vehicles to fly letters to remote areas in the UK. 'If you take, say, the Scilly Isles - an expensive piece of water [to cross] - they might be ideally suited to a drone,' he says. - Mail on Sunday

More Leave voters than Remainers have swung from the Tories to Labour since the last election, according to a major polling project that suggests Keir Starmer, the Labour leader, has made some early progress in bridging the Brexit divide. A large 7,000-strong poll, designed to examine the political changes that have taken place since Labour's disastrous result, found that the party was showing signs of winning over some of those who backed the Tories last year. - Guardian

Giant American fashion and investment corporations are eyeing up bids for Topshop and its parent group Arcadia. [...] Around 30 to 40 potential buyers are believed to have shown initial interest and have received a limited information pack on the business from Arcadia's administrators, Deloitte. First-round bids are due in by the end of this week. - Mail on Sunday

A French satellite giant is muscling in on Britain's broadband market by targeting half a million people in the remotest parts of the nation. Eutelsat has launched Konnect, a satellite broadband service for homes that will not benefit from industry efforts to carpet Britain in gigabit speed connectivity. The service was rolled-out in the UK last week ahead of expanding across Europe and parts of Africa using the same satellite infrastructure. - Sunday Telegraph

Mike Ashley is racing to complete a deal to buy Debenhams this weekend, sources have told The Mail on Sunday. The sportswear mogul is in talks to buy the £500million web business - to help him crack the high-end cosmetics market - but the Debenhams store chain has been vastly slimmed down. 'There's very little time left to rescue the business,' said one City source. 'But without at least 30 or 40 of the 124Nightcap stores, this might not look very much like a rescue at all.' - Mail on Sunday

Dragons' Den entrepreneur Sarah Willingham is preparing to float a chain of city-centre bars with a team including celebrity chef Raymond Blanc, despite the malaise gripping leisure. Willingham, 46, has agreed a counterintuitive deal to buy London Cocktail Club through a stock market listing of her investment vehicle, Nightcap, on AIM in the coming weeks. She plans to raise £6m at a valuation of £14m. - Sunday Times



More News
8 Mar 2024 06:00

Astra, Sanofi's antibody 90% effective against RSV in infants - CDC

(Alliance News) - A new treatment for infant respiratory syncytial virus, RSV, – a leading cause of severe illness in US babies – is 90% effective in preventing hospitalization, health authorities said Thursday.

Read more
6 Mar 2024 14:40

UK BUDGET: Some tax cuts but vapes, tobacco and non-doms targeted

(Alliance News) - A cut to national insurance, stamp duty relief as well as a freeze on fuel and alcohol duties were among the marquee tax measures that UK Chancellor Jeremy Hunt announced in his budget on Wednesday.

Read more
5 Mar 2024 14:24

AstraZeneca's breast cancer treatment blocked for NHS use in England

(Alliance News) - A treatment that extends the life of people with advanced breast cancer has been blocked for NHS use in England in a move that potentially impacts thousands of patients.

Read more
4 Mar 2024 09:31

AstraZeneca and Daiichi Sankyo get EU approval for cancer treatment

(Alliance News) - AstraZeneca PLC and Daiichi Sankyo Co Ltd on Monday said that the European Medicines Agency has approved two marketing authorisation applications for their datopotamab deruxtecan in two types of cancer.

Read more
4 Mar 2024 07:18

AstraZeneca's chemo replacement treatment moves closer to EU approval

(Sharecast News) - European regulators have validated two marketing authorisation applications (MMAs) for AstraZeneca, as the biopharma giant's datopotamab deruxtecan chemotherapy replacement treatment comes one step closer to receiving the green light to treat two types of cancer.

Read more
26 Feb 2024 08:51

AstraZeneca's Voydeya treatment recommended for EU approval

(Alliance News) - AstraZeneca on Monday announced further support from regulators for its first-in-class blood disease treatment.

Read more
26 Feb 2024 07:22

AstraZeneca's blood-disorder drug recommended for EU approval

(Sharecast News) - European regulators has given the green light to AstraZeneca's blood-disorder drug Voydeya, the biopharma giant announced on Monday.

Read more
22 Feb 2024 17:36

EARNINGS AND TRADING: Astra closes Gracell buy, Amicorp "on track"

(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and Thursday and not separately reported by Alliance News:

Read more
20 Feb 2024 10:29

AstraZeneca acquires US-based biopharmaceutical company

(Sharecast News) - Drugmaker AstraZeneca revealed late on Monday afternoon that it had successfully completed its acquisition of US-based biopharmaceutical company Icosavax.

Read more
20 Feb 2024 09:40

LONDON BROKER RATINGS: JPMorgan cuts Airtel Africa price target by 28%

(Alliance News) - The following London-listed shares received analyst recommendations Tuesday morning and Monday:

Read more
19 Feb 2024 16:51

LONDON MARKET CLOSE: Europe lacks direction on quiet Monday

(Alliance News) - European markets lacked direction on Monday, after a quiet day as the US markets celebrated George Washington's birthday.

Read more
19 Feb 2024 15:59

London close: Stocks manage gains on globally quiet day

(Sharecast News) - London's financial markets finished in positive territory on Monday, with stocks closing in the green after overcoming minor losses earlier in the session.

Read more
19 Feb 2024 15:39

UPDATE: AstraZeneca completes USD1.1 billion acquisition of Icosavax

(Alliance News) - AstraZeneca PLC on Monday said it has completed the acquisition of Icosavax Inc.

Read more
19 Feb 2024 11:51

LONDON MARKET MIDDAY: Stocks lack direction amid quiet start to week

(Alliance News) - Stock prices in London lacked direction at midday Monday, amid a quiet start to the week.

Read more
19 Feb 2024 08:44

LONDON MARKET OPEN: Stocks drift; Currys surges on takeover interest

(Alliance News) - Stock prices in London were looking for direction early Monday, as investors weighed possible trajectories for US interest rate cuts and a China's economic recovery.

Read more

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.